CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +50.0% | 1,585 | +107.2% | 0.00% | – |
| Q2 2023 | $2 | -60.0% | 765 | -31.3% | 0.00% | – |
| Q1 2023 | $5 | -37.5% | 1,114 | +42.6% | 0.00% | – |
| Q4 2022 | $8 | -100.0% | 781 | -61.6% | 0.00% | – |
| Q3 2022 | $19,000 | 0.0% | 2,036 | -2.2% | 0.00% | – |
| Q2 2022 | $19,000 | -24.0% | 2,081 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -3.8% | 2,081 | -2.3% | 0.00% | – |
| Q4 2021 | $26,000 | +23.8% | 2,131 | +42.6% | 0.00% | – |
| Q2 2021 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q4 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q2 2019 | $21,000 | 0.0% | 1,494 | 0.0% | 0.00% | – |
| Q1 2019 | $21,000 | – | 1,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
| Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
| Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
| DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
| Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
| DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
| B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |